Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.

Journal of genetic counseling - 1 Feb 2013

Hoskins Lindsey M, Werner-Lin Allison

Abstract excerpt

Much of the extant literature addressing the psychosocial aspects of BRCA1/2 mutation testing and risk management aggregates mutation carriers of all ages in study recruitment, data analysis, and interpretation. This analytic strategy does not adequately address the needs of the youngest genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Pedigree

Share to Risk Management

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 22864682
DOI: 10.1007/s10897-012-9521-y
PMCID: PMC3529763

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22864682-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.PMID 22864682Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Reproductive decision-making in young female carriers of a BRCA mutation.Semantic proximity Read ↗

“I need to know if I’m going to die young”: Adolescent and young adult experiences of genetic testing for Li–Fraumeni syndromeSemantic proximity Read ↗

Predictive Testing of Eighteen Year Olds: Counseling ChallengesSemantic proximity Read ↗

Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.Semantic proximity Read ↗

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.Semantic proximity Read ↗

Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations.Semantic proximity Read ↗

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.Semantic proximity Read ↗

Cancer risk management decision making for BRCA+ women.Semantic proximity Read ↗

Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.Semantic proximity Read ↗

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.